Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/221924
Title: | The interstitial lung disease patient pathway: from referral to diagnosis |
Author: | Lough, Graham Abdulqawi, Rayid Amanda, Gina Antoniou, Katerina Azuma, Arata Baldi, Milind Bayoumy, Ahmed Behr, Jürgen Bendstrup, Elisabeth Bouros, Demosthenes Brown, Kevin Chaudhuri, Nazia Corte, Tamera J. Cottin, Vincent Crestani, Bruno Flaherty, Kevin R. Glaspole, Ian Kawano Dourado, Leticia Keane, Michael P. Kolb, Martin Martínez, Fernando J. Molina Molina, María Ojanguren Arranz, Iñigo Pearmain, Laurence Raghu, Ganesh Rottoli, Paola Stanel, Stefan C. Tabaj, Gabriela Vancheri, Carlo Varela, Brenda Wang, Bonnie Wells, Athol Rivera Ortega, Pilar |
Keywords: | Malalties del pulmó Diagnòstic Pulmonary diseases Diagnosis |
Issue Date: | 10-Oct-2024 |
Publisher: | European Respiratory Society (ERS) |
Abstract: | Background Suspected interstitial lung disease (ILD) patients may be referred to an ILD-specialist centre or a non-ILD-specialist centre for diagnosis and treatment. Early referral and management of patients at ILD-specialist centres has been shown to improve survival and reduce hospitalisations. The COVID-19 pandemic has affected the ILD patient diagnostic pathway and prompted centres to adapt. This study investigates and contrasts ILD patient pathways in ILD-specialist and non-ILD-specialist centres, focusing on referrals, caseloads, diagnostic tools, multi-disciplinary team (MDT) meeting practices and resource accessibility. Methods Conducted as a cross-sectional study, a global self-selecting survey ran from September 2022 to January 2023. Participants included ILD specialists and healthcare professionals (HCPs) from ILDspecialist centres and non-ILD-specialist centres. Results Of 363 unique respondents from 64 countries, 259 were from ILD-specialist centres and 104 from non-ILD-specialist centres. ILD centres had better resource availability, exhibiting higher utilisation of diagnostic tests (median: 12 tests) than non-ILD centres (nine tests) and better access to specialist professions attending MDT meetings (median: six professions at meeting) in specialist centres than nonILD centres (three professions at meeting). Transitioning to virtual MDT meetings allowed HCPs from other locations to join meetings in nearly 90% of all centres, increasing regular participation in 60% of specialist centres and 72% of non-ILD centres. For treatment of patients, specialist centres had better access to antifibrotic drugs (91%) compared to non-ILD centres (60%). Conclusions Diagnostic pathways for ILD patients diverged between specialist centres and non-ILD centres. Disparities in resource and specialist availability existed between centres. |
Note: | Reproducció del document publicat a: https://doi.org/10.1183/23120541.00899-2024 |
It is part of: | ERJ Open Research, 2024, vol. 11, num. 2 |
URI: | https://hdl.handle.net/2445/221924 |
Related resource: | https://doi.org/10.1183/23120541.00899-2024 |
ISSN: | 2312-0541 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ERJ Open Res-2025-Lough-00899-2024.pdf | 1.09 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License